JANUMET XR cpr pell ret 50/500 mg fl 56 pce

7680650520023 CH-65052 A10BD07 07.06.2.

Reimbursement limitations:

JANUMET3

Pour le traitement des patients diabétiques de type 2 qui ne peuvent pas être suffisamment …

JANUMET XR cpr pell ret 50/500 mg fl 56 pce
JANUMET XR cpr pell ret 50/500 mg fl 56 pce
JANUMET XR cpr pell ret 50/500 mg fl 56 pce
1 / 3
google

Details

Product number
6505201
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
metformini hydrochloridum 500.0 mg, sitagliptini phosphas monohydricus 64.25 mg corresp. sitagliptinum 50 mg, povidonum K 29-32, hypromellosum, cellulosum microcristallinum, silica colloidalis anhydrica, natrii stearylis fumaras corresp. natrium 1.26 mg, E 310, macrogolum 3350, kaolinum leve, Überzug: hypromellosum, hydroxypropylcellulosum, E 171, E 132, cera carnauba, pro compresso obducto.

Articles (1)

Janumet XR 50 mg/500 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/01/2024
Patient information leaflet
Français
24/01/2024
Patient information leaflet
Italien
24/01/2024
Professional SmPC
Allemand
11/12/2023
Professional SmPC
Français
11/12/2023
Professional SmPC
Italien
11/12/2023

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
64.25 MG Substance WIZUS
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.26 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 38.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2015

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
65052
Drug name
Janumet XR, Filmtabletten
Galenic form
TABWF
ATC Code
A10BD07
Authorization status
Z
Dispensation category
B
First authorization
30/07/2014
Authorization expiration date
31/12/9999
IT number
07.06.2.
Domain
Human medicine
Field of application
orales Antidiabetikum

Packaging details

Description (FR)
JANUMET XR 50 mg/ cpr ret 500 mg 56 pce
Description (DE)
JANUMET XR 50 mg/ Ret Tabl 500 mg 56 Stk
Market launch
30/07/2014
Narcotic (BTM)
No

Available generics

Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 26.75
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 52.60
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 26.75
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 52.60
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 34.85
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 26.75
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 52.60
View
Sitagliptin-Metformin-Mepha, Filmtabletten
CHF 34.85
View
Sitagliptin-Metformin-Mepha retard, Tabletten mit veränderter Wirkstofffreisetzung
CHF 33.10
View
Sitagliptin-Metformin-Mepha retard, Tabletten mit veränderter Wirkstofffreisetzung
CHF 60.25
View

Other packaging sizes

JANUMET XR 50 mg/ cpr ret 500 mg 168 pce
168 TABL
View
JANUMET XR 50 mg/ cpr ret 1000 mg 56 pce
56 TABL
View
JANUMET XR 50 mg/ cpr ret 1000 mg 168 pce
168 TABL
View
JANUMET XR 100 mg/ cpr ret 1000 mg 28 pce
28 TABL
View
JANUMET XR 100 mg/ cpr ret 1000 mg 84 pce
84 TABL
View